#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14850	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2030	719.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	852	C	836	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	0	.	n	.	0	A20C	SNP	20	20	A	353	353	C	477	C,A	441,27	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	0	.	n	.	0	T695C	SNP	695	695	T	1028	1028	C	813	C,T	801,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1971	1971	G	930	G,A	883,32	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2304	2304	C	819	C,T	796,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2378	2378	A	848	A	832	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26414	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3565	735.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2930	2930	C	854	C,T,G	839,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1932	folP	855	855	100.0	folP.l15.c4.ctg.1	1535	124.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1063	1065	AGC	174;176;172	A,C;G;C,T	167,4;174;167,3	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	160.2	1	SNP	p	S91F	1	.	.	271	273	TTC	657	659	TTC	191;192;196	T,A;T,C;C	186,1;184,1;188	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	160.2	1	SNP	p	G95N	0	.	.	283	285	GGC	669	671	GGC	192;193;194	G;G,A;C	188;187,3;189	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	160.2	1	SNP	p	D95G	1	.	.	283	285	GGC	669	671	GGC	192;193;194	G;G,A;C	188;187,3;189	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1712	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1627	104.6	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1042	1044	TTG	188;187;189	T,G;T;G,C	184,1;180;173,10	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1712	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1627	104.6	1	SNP	p	G45D	0	.	.	133	135	GGC	625	627	GGC	201;200;197	G;G,A;C	197;195,2;193	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	878	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1009	86.3	0	.	n	.	0	A197.	DEL	197	197	A	546	546	A	207	A	204	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2840	168.9	1	SNP	p	D86N	0	.	.	256	258	GAC	526	528	GAC	194;193;192	G;A;C	190;179;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2840	168.9	1	SNP	p	R87W	0	.	.	259	261	CGT	529	531	CGT	189;189;192	C,A;G;T	181,4;183;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2840	168.9	1	SNP	p	S87R	1	.	.	259	261	CGT	529	531	CGT	189;189;192	C,A;G;T	181,4;183;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2840	168.9	1	SNP	p	R87I	0	.	.	259	261	CGT	529	531	CGT	189;189;192	C,A;G;T	181,4;183;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2840	168.9	1	SNP	p	S88P	0	.	.	262	264	TCC	532	534	TCC	193;193;193	T;C;C	188;184;189	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4150	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2659	155.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	203;195;191	G;G;C	199;191;184	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1223	1225	GCA	187;193;196	G;C;A,C	183;186;190,2	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1226	1228	ATC	195;195;199	A;T;C,G,T	193;193;193,2,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1238	1240	GTG	205;206;205	G;T;G	203;204;203	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1238	1240	GTG	205;206;205	G;T;G	203;204;203	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1742	1744	ACC	192;191;195	A;C;C	182;188;192	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1796	1798	GCG	185;184;183	G;C,G;G	175;163,3;170	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1796	1798	GCG	185;184;183	G;C,G;G	175;163,3;170	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1919	1921	AGC	166;165;166	A,G;G,A;C,T	157,5;164,1;160,5	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1928	1930	GGC	153;151;152	G,A;G;C	149,3;150;147	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3888	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	155.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1946	1948	CCG	119;120;123	C,G;C,G;G	103,1;107,1;109	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5602	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3056	181.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2568	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1917	132.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	594	594	C	173	C	166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	451	453	GAA	210;210;213	G;A;A	205;204;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	862	864	TCA	202;202;201	T;C;A	195;200;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	991	993	GTC	216;219;217	G;T;C	207;203;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1003	1005	TCT	218;220;223	T;C,T;T	211;212,2;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1321	1323	GCA	218;216;218	G;C,A;A	217;209,7;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	1	SNP	p	G120K	1	.	.	358	360	AAG	697	699	AAG	180;177;177	A,G;A,G;G,T	172,2;173,2;170,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	1	SNP	p	A121D	1	.	.	361	363	GAC	700	702	GAC	177;178;176	G,A;A,C;C,A	173,1;171,2;173,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2690	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1742	153.1	1	SNP	p	D121N	0	.	.	361	363	GAC	700	702	GAC	177;178;176	G,A;A,C;C,A	173,1;171,2;173,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	296	porB3	990	174	96.55	porB3.l6.c4.ctg.3	180	1.9	0	.	p	.	0	T29A	NONSYN	85	87	ACC	28	30	GCC	2;2;2	G;C;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	296	porB3	990	174	96.55	porB3.l6.c4.ctg.3	180	1.9	0	.	p	.	0	I75V	NONSYN	223	225	ATT	166	168	GTT	2;2;2	G,A;T;T	0,2;2;2	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9746	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4784	202.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1138	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1146	98.6	1	SNP	p	V57M	1	.	.	169	171	ATG	549	551	ATG	222;228;223	A,G;T;G	215,2;223;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	528	8	tetM	1920	262	99.24	tetM.l15.c30.ctg.1	262	1.9	0	.	p	.	0	P280S	NONSYN	838	840	CCG	95	97	TCG	2;4;4	T;C;G	2;3;3	.	Tetracycline resistance
